Home › Funds › Atle Fund Management AB › DXCM

Atle Fund Management AB position in DXCM

DEXCOM · Health Care

Atle Fund Management AB reported holding 89,251 shares of DXCM (DEXCOM) in its Q3 2026 13F filing — a position valued at US$7.7M, representing 2.06% of its reported portfolio and ranking #19 among its reported holdings. Atle Fund Management AB has disclosed DXCM holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)89.25K sh
Reported value held$7.70M
Portfolio Weight2.06%
First reportedQ4 2023
Last changeAdd
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Atle Fund Management AB's DXCM position evolved

Atle Fund Management AB first disclosed a stake in DXCM in Q4 2023 at 18,057 shares (US$2.2M). The position peaked in Q3 2026 at 89,251 shares, worth US$7.7M. Across 12 filings, Atle Fund Management AB increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 89,251 shares valued at US$7.7M — an increase of 17,405 shares quarter over quarter.. Notable position changes include a 56% increase in Q3 2024 (shares rose 17% over the following quarter), a 1371% increase in Q1 2026 (shares rose 7% over the following quarter), a 88% trim in Q2 2026 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 18.06K $2.24M New
Q1 2024 26.28K $3.65M Add
Q2 2024 34.48K $3.91M Add
Q3 2024 53.76K $3.60M Add
Q4 2024 60.06K $4.68M Add
Q1 2025 45.84K $3.13M Reduce
Q2 2025 50.87K $4.44M Add
Q3 2025 50.87K $363.42K Hold
Q4 2025 39.72K $2.64M Reduce
Q1 2026 584.33K $2.64M Add
Q2 2026 71.85K $4.84M Reduce
Q3 2026 89.25K $7.70M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DXCM and 13F data

DXCM (DEXCOM) is a Health Care company. 27 other funds we track also report a position in DXCM — the largest reported positions include Baillie Gifford & Co (US$996.9M), Castle Hook Partners LP (US$260.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DXCM

All DXCM fund holders →

FAQ

How long has Atle Fund Management AB held DXCM?

Atle Fund Management AB has disclosed DXCM holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is Atle Fund Management AB's current position in DXCM?

As of Q3 2026, Atle Fund Management AB holds 89.25K shares of DXCM (DEXCOM), valued at $7.70M, representing 2.06% of its reported portfolio and ranking #19.

Has Atle Fund Management AB been buying or selling DXCM?

In the latest 13F filing (Q3 2026), Atle Fund Management AB increased its position in DXCM. The position peaked in Q3 2026 at 89.25K shares.

Which other funds hold DXCM?

Other major institutional holders of DXCM include Baillie Gifford & Co, Castle Hook Partners LP, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.